North Oxford, MA, United States of America

Karen L Erickson


Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • N. Oxford, MA (US) (2002)
  • North Oxford, MA (US) (2016)

Company Filing History:


Years Active: 2002-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Karen L. Erickson

Introduction

Karen L. Erickson, an accomplished inventor based in North Oxford, MA, has made significant contributions to the field of cancer treatment through her groundbreaking patents. With two patents to her name, her work exemplifies the fusion of innovation and science aimed at improving therapeutic outcomes for patients suffering from cancer.

Latest Patents

Among her latest patents is a method for sensitizing cancer cells to the cytotoxic effects of death receptor ligands in cancer treatment. This innovative approach involves enhancing the response of cancer cells in mammals to treatment with death receptor ligands by combining it with effective compounds such as cucurbitacins or withanolides. Additionally, she has introduced a method for inducing apoptosis in cancer cells, utilizing the same class of compounds in conjunction with death receptor ligands to facilitate the programmed cell death crucial for combating cancer.

Another notable patent by Karen addresses macrocyclic lactones, providing compositions and methods of use that further her research in uncovering new avenues for cancer treatment. Her work has the potential to pave the way for new therapeutic strategies that could enhance the efficacy of current cancer therapies.

Career Highlights

Karen L. Erickson is associated with the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services. Her collaborative efforts in this capacity have led to the development of innovative methods and compounds that play a critical role in the evolving landscape of cancer treatment.

Collaborations

Throughout her career, Karen has partnered with notable colleagues such as Thomas Joseph Sayers and Nancy Lynn Booth, showcasing her commitment to collaborative research. These partnerships have enabled her to leverage diverse expertise and perspectives in her innovative projects.

Conclusion

Karen L. Erickson stands out as a prominent inventor in the realm of cancer treatment innovations. Her patents reflect a deep understanding of complex biological processes and underscore her dedication to making a real-world impact. As cancer research continues to evolve, Karen's contributions will undoubtedly play a pivotal role in shaping the future of therapeutic strategies and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…